mRNA冠状病毒-2019疫苗接种后morphea的再激活

Q4 Medicine

Turkderm-Archives of the Turkish Dermatology and Venerology Pub Date : 2023-04-04 DOI:10.4274/turkderm.galenos.2023.22208

Malik Güngör, A. Bilgic

{"title":"mRNA冠状病毒-2019疫苗接种后morphea的再激活","authors":"Malik Güngör, A. Bilgic","doi":"10.4274/turkderm.galenos.2023.22208","DOIUrl":null,"url":null,"abstract":"Morphea is an inflammatory immune-mediated disease associated with many factors such as genetic predisposition, environmental triggers such as bacterial and viral infections, as well as intrinsic factors such as hormonal and immunological dysregulation, although its pathogenesis is largely unknown. Here, we report the first case of morphea relapse after the mRNA coronavirus disease-2019 (COVID-19) vaccine. Our case along with recent reports suggest that new associations might appear due to COVID-19 infection and vaccines.","PeriodicalId":49412,"journal":{"name":"Turkderm-Archives of the Turkish Dermatology and Venerology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reactivation of morphea following mRNA coronavirus disease-2019 vaccination\",\"authors\":\"Malik Güngör, A. Bilgic\",\"doi\":\"10.4274/turkderm.galenos.2023.22208\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Morphea is an inflammatory immune-mediated disease associated with many factors such as genetic predisposition, environmental triggers such as bacterial and viral infections, as well as intrinsic factors such as hormonal and immunological dysregulation, although its pathogenesis is largely unknown. Here, we report the first case of morphea relapse after the mRNA coronavirus disease-2019 (COVID-19) vaccine. Our case along with recent reports suggest that new associations might appear due to COVID-19 infection and vaccines.\",\"PeriodicalId\":49412,\"journal\":{\"name\":\"Turkderm-Archives of the Turkish Dermatology and Venerology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Turkderm-Archives of the Turkish Dermatology and Venerology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4274/turkderm.galenos.2023.22208\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkderm-Archives of the Turkish Dermatology and Venerology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/turkderm.galenos.2023.22208","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

Morphea是一种炎症性免疫介导的疾病，与许多因素相关，如遗传易感性、细菌和病毒感染等环境触发因素，以及激素和免疫失调等内在因素，尽管其发病机制在很大程度上尚不清楚。在这里，我们报告了首例mRNA冠状病毒病-2019 (COVID-19)疫苗接种后吗啡复发的病例。我们的病例以及最近的报告表明，由于COVID-19感染和疫苗可能会出现新的关联。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Reactivation of morphea following mRNA coronavirus disease-2019 vaccination

Morphea is an inflammatory immune-mediated disease associated with many factors such as genetic predisposition, environmental triggers such as bacterial and viral infections, as well as intrinsic factors such as hormonal and immunological dysregulation, although its pathogenesis is largely unknown. Here, we report the first case of morphea relapse after the mRNA coronavirus disease-2019 (COVID-19) vaccine. Our case along with recent reports suggest that new associations might appear due to COVID-19 infection and vaccines.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Turkderm-Archives of the Turkish Dermatology and Venerology DERMATOLOGY-

CiteScore

0.30

自引率

0.00%

发文量

审稿时长

6-12 weeks